Previous evidences in cell lines, knockout animals, and primary human cancer tissues have indicated that RUNX3 as a suppressor is inactivated in BC by reduced copy number [14], protein mislocalization [10, 15], hemizygous deletion and promoter hypermethylation [16–18]. This evidence concerns the gene RUNX3 and cancer.